f i in
🔍

Fonkozomib 3.5mg

Fonkozomib (Bortezomib) is a proteasome inhibitor used to target and treat multiple myeloma and mantle cell lymphoma with confidence.

Fonkozomib 3.5mg

Fonkozomib 3.5mg

Generic Name: Bortezomib

Indications

  • Multiple myeloma.
  • Mantle cell lymphoma.

Strength: 3.5 mg

Pack Size: Vial

Dosage Form: Powder for solution for injection

Categories: Pharmaceuticals

Therapeutic Class: Proteasome Inhibitor

Products Information

OUR PROMISE TO OUR PEOPLE

Our Partners

Business Relationship

At Amgomed, we recognize that robust business relationships are pivotal in delivering superior healthcare solutions. As an established entity in the pharmaceutical industry, we have cultivated enduring partnerships with global manufacturers to introduce innovative oncology products to patients across Pakistan.